Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Novella Russo"'
Autor:
Novella Russo, Caterina Mammi, Maurizio Volterrani, Massimo Fini, Cristiana Vitale, Marco Gambacciani, Ilaria Spoletini, Giuseppe M.C. Rosano
Publikováno v:
International Journal of Cardiology. 227:217-221
Drospirenone (DRSP) is an antialdosterone agent with progestogenic and antiandrogenic effects. This compound, has been recently used in combination with 17β-estradiol (E2) as hormonal therapy in postmenopausal women and has been shown to exert a sig
Autor:
Marco Gambacciani, Anna Maria Paoletti, Manuela Farris, P Vanhauwaert, Nicoletta Biglia, Salvatore Caruso, M. Parra, Paola Villa, C. Campusano, Alessandro Gambera, Ettore Cicinelli, C. Di Carlo, M. Levancini, M. Villarroel, V. De Leo, Pablo Lavín, P. Barriga, S. Guaschino, S. Brantes, Ernesto Pizarro, M Fernadez, Antonio Lanzone, N. Lagos, F. Vicariotto, Angelo Cagnacci, Annibale Volpe, S. Velasco, M. Lopez, Novella Russo
Publikováno v:
Revista chilena de obstetricia y ginecología, Volume: 83, Issue: 5, Pages: 527-550, Published: NOV 2018
Revista chilena de obstetricia y ginecología v.83 n.5 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
Revista chilena de obstetricia y ginecología v.83 n.5 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
In the last decade, the risk benefits ratio of MHT has been evaluated mainly in terms of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausal Hormone Therapy in 2013 and 2016 by leading global men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::decd6c565e336ba2b1fe72037e642875
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262018000500527&lng=en&tlng=en
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262018000500527&lng=en&tlng=en
Menopause and hormone replacement therapy. The 2017 recommendations of the Italian Menopause Society
Autor:
Marco, Gambacciani, Nicoletta, Biglia, Angelo, Cagnacci, Salvatore, Caruso, Ettore, Cicinelli, Vincenzo, DE Leo, Costantino, DI Carlo, Manuela, Farris, Alessandro, Gambera, Secondo, Guaschino, Antonio, Lanzone, Anna M, Paoletti, Novella, Russo, Franco, Vicariotto, Paola, Villa, Annibale, Volpe
Over the last decade, the risk benefits ratio of hormone replacement therapy (HRT) has been reevaluated mainly in tens of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausal Hormone Therapy in 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e6fbc36c87e326058c74fb31dc5816
http://hdl.handle.net/2318/1660014
http://hdl.handle.net/2318/1660014
Autor:
Novella Russo
Publikováno v:
Maturitas. 81:178
Objectives: To evaluate the effect of low dose HRT on quality of life. Blood pressure, BMI, joint pain and vaginal lubrication. Methods: Postmenopausal symptomatic women untreated with HRT in the previous 12 months were randomized to Calcium Carbonat